Related Experiment Video

Updated: Jul 16, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

[Recent progress in pediatric stem cell transplantation]

Kimikazu Matsumoto1, Koji Kato

  • 1Division of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 16, 2007
PubMed

Insights

Pediatric hematopoietic stem cell transplantation (SCT) is complex, with fewer transplants due to population changes and better therapies. Advances aim to improve outcomes for cord blood transplants by addressing rejection and relapse risks.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Transplantation Immunology

Context:

  • Pediatric hematopoietic stem cell transplantation (SCT) is an established but increasingly sophisticated procedure.
  • Despite advances in conditioning and stem cell sources, the overall number of pediatric SCTs has declined.
  • Factors contributing to the decline include a shrinking pediatric population and progress in chemotherapy and targeted therapies.

Purpose:

  • To review the current landscape and challenges in pediatric SCT.
  • To discuss strategies for improving outcomes in cord blood (CB) transplantation, including cell dose and HLA matching.
  • To highlight the importance of reduced intensity preparative regimens and managing late complications in pediatric SCT.

Summary:

  • Pediatric SCT faces challenges including declining transplant numbers and specific issues with cord blood (CB) transplants, such as rejection and high relapse rates in advanced diseases.
  • Strategies to improve CB transplantation involve selecting CB with a high cell count and HLA matching.
  • Reduced intensity preparative regimens are being explored to minimize complications, while long-term survivors require monitoring for growth failure and secondary malignancies.

Impact:

  • Advances in conditioning regimens and stem cell sources enhance eligibility for pediatric SCT.
  • Optimizing CB selection and exploring reduced intensity regimens can mitigate rejection and relapse.
  • Addressing late complications like growth failure and secondary malignancies is crucial for improving the quality of life for long-term pediatric SCT survivors.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...